// App-Quantinova.ai

191 : Effectiveness and safety of switch to rituximab biosimilar with rheumatoid arthritis. a single centre experience

Researchers

Presenter

  • Benazir Saleem

Principal Investigators

  • Lynda Bailey

  • Leticcia Garcia Montoya

  • Yuzaifal Yusof

  • Edward M Vital

  • Paul Emery

  • Jaqueline L Nam

  • Shouvik Dass

  • Maya Buch

Medical Centers

  • Respiratory, Leeds Teaching Hospitals NHS Trust, Leeds, UNITED KINGDOM

  • Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, UK

  • NIHR Biomedical Research Centre, Leeds Teaching Hospitals NHS Trust, Leeds, UNITED KINGDOM

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Rheumatoid arthritis

Biomarkers

  • N/A

Drug/Treatment

  • Rituximab biosimilar

  • Rituximab

  • Rituximab-abbs

Outcome

  • N/A

Study Design

  • Cohort

  • Single Center

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved